EcoDrugPlus

Ensembl ID : ENSJJAG00000023733
Gene Symbol: -
Cross references: -
173 Possible Orthologues:

Ensembl ID : ENSJJAG00000006526
Gene Symbol: -
Cross references: -
19 Possible Orthologues:

Ensembl ID : ENSJJAG00000010411
Gene Symbol: -
Cross references: -
205 Possible Orthologues:

Ensembl ID : ENSJJAG00000010762
Gene Symbol: -
Cross references: -
181 Possible Orthologues:

Ensembl ID : ENSJJAG00000017944
Gene Symbol: -
Cross references: -
248 Possible Orthologues:

Ensembl ID : ENSJJAG00000022058
Gene Symbol: -
Cross references: -
207 Possible Orthologues:

Ensembl ID : ENSJJAG00000022248
Gene Symbol: -
Cross references: -
250 Possible Orthologues:

Ensembl ID : ENSJJAG00000022492
Gene Symbol: -
Cross references: -
229 Possible Orthologues:

Ensembl ID : ENSJJAG00000021722
Gene Symbol: -
Cross references: -
233 Possible Orthologues:

Ensembl ID : ENSJJAG00000010649
Gene Symbol: -
Cross references: -
197 Possible Orthologues:

Ensembl ID : ENSJJAG00000006533
Gene Symbol: -
Cross references: -
159 Possible Orthologues:

Ensembl ID : ENSJJAG00000014575
Gene Symbol: -
Cross references: -
159 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).